Cargando…

Effective treatment of advanced Hodgkin lymphoma with a modified BEACOPP regimen for a patient with demyelinating hereditary motor and sensory neuropathy type 1 (HMSN1)

Treatment for Hodgkin lymphoma (HL) in adults comprises substantial risk of chemotherapy‐induced peripheral neurotoxicity. Here, we describe the case of patient with Charcot–Marie–Tooth disease or HSMN1 and advanced Hodgkin lymphoma undergoing treatment with modified BEACOPP achieving complete remis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hess, Patrick P., Ventura Ferreira, Monica S., Rolles, Benjamin, Kirschner, Martin, Holtbernd, Florian, Tometten, Mareike, Brümmendorf, Tim H., Beier, Fabian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069391/ https://www.ncbi.nlm.nih.gov/pubmed/35540715 http://dx.doi.org/10.1002/ccr3.5766

Ejemplares similares

ABVD and BEACOPP regimens’ effects on fertility in young males with Hodgkin lymphoma
por: Amin, M. S. A., et al.
Publicado: (2020)

ABVE-PC and modified BEACOPP regimen in Indian children with Hodgkin lymphoma: Feasibility and efficacy
por: Jayabose, Somasundaram, et al.
Publicado: (2016)

Comparable Effects of the Androgen Derivatives Danazol, Oxymetholone and Nandrolone on Telomerase Activity in Human Primary Hematopoietic Cells from Patients with Dyskeratosis Congenita
por: Vieri, Margherita, et al.
Publicado: (2020)

Demyelination in hereditary sensory neuropathy type‐1C
por: Saba, Sadaf, et al.
Publicado: (2020)

P016: Reduced steroid exposure is safe and does not reduce disease control among Hodgkin Lymphoma patients treated with escalated BEACOPP (eBEACOPP)
por: Dragičević, Ida Hude, et al.
Publicado: (2022)

Transient elastography in adult patients with cryptic dyskeratosis congenita reveals subclinical liver fibrosis: a retrospective analysis of the Aachen telomere biology disease registry
por: Tometten, Mareike, et al.
Publicado: (2021)

Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP
por: Jachimowicz, Ron D., et al.
Publicado: (2021)

T065: Reproduction patterns among Classical Hodgkin Lymphoma Survivors Treated with BEACOPP and ABVD in Sweden, Denmark, and Norway
por: Entrop, Joshua P., et al.
Publicado: (2022)

Transferrin receptor-targeted HMSN for sorafenib delivery in refractory differentiated thyroid cancer therapy
por: Ke, You, et al.
Publicado: (2018)

Proteasome impairment in neural cells derived from HMSN-P patient iPSCs
por: Murakami, Nagahisa, et al.
Publicado: (2017)

In vivo targeting of breast cancer with a vasculature-specific GQDs/hMSN nanoplatform
por: Dong, Jingjing, et al.
Publicado: (2019)

Telomere Shortening in Peripheral Leukocytes Is Associated With Poor Survival in Cancer Patients Treated With Immune Checkpoint Inhibitor Therapy
por: Rolles, Benjamin, et al.
Publicado: (2021)

Telomere length dynamics measured by flow-FISH in patients with obesity undergoing bariatric surgery
por: Rolles, Benjamin, et al.
Publicado: (2023)

Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials
por: André, Marc P. E., et al.
Publicado: (2020)

Preparation of core/shell CdTe@hMSN for enhanced tumor vasculature-specific drug delivery
por: Yang, Dongzhi, et al.
Publicado: (2018)

Survival rates of adult patients with Hodgkin lymphoma who underwent ABVD versus escalated BEACOPP in a resource‐limited country: An observational study
por: Suwanban, Tawatchai, et al.
Publicado: (2023)

P007: Comparative efficacy of the R-BEACOPP-14 and R-CHOP regimens in the treatment of patients with advanced stages of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) with THRLBCL-like histopathological growth patterns in the tumor biopsy
por: Dorokhina, Elena, et al.
Publicado: (2022)

Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group
por: Damaschin, Carla, et al.
Publicado: (2021)

P068: A Retrospective Analysis of Fertility in Female Patients with Advanced Stages of Hodgkin Lymphoma Treated with BEACOPP Escalated Chemotherapy (25 Year Experience of a Single Centre)
por: Marková, Jana, et al.
Publicado: (2022)

P804: EX VIVO TREATMENT WITH ELTROMBOPAG RESCUES HEMATOPOIETIC STEM CELLS FROM ANTI-THYMOCYTE GLOBULIN-RELATED DAMAGE DURING IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH APLASTIC ANEMIA
por: Vieri, M., et al.
Publicado: (2022)

Whole-slide image analysis of the tumor microenvironment identifies low B-cell content as a predictor of adverse outcome in patients with advanced-stage classical Hodgkin lymphoma treated with BEACOPP
por: Jachimowicz, Ron Daniel, et al.
Publicado: (2020)

P023: PET2-adapted approach after 2 cycles of ABVD is comparable to 2 cycles of BEACOPP escalated and 2 cycles of ABVD and irradiation in early unfavorable Hodgkin lymphoma
por: Mocikova, Heidi, et al.
Publicado: (2022)

Behind the pathology of macrophage-associated demyelination in inflammatory neuropathies: demyelinating Schwann cells
por: Park, Hwan Tae, et al.
Publicado: (2019)

Ankle Fracture in Hereditary Sensory Neuropathy Type 1
por: Loh, Jeremy, et al.
Publicado: (2021)

Motor demyelinating tibial neuropathy in COVID-19
por: Daia, Cristina, et al.
Publicado: (2021)

HTLV-1-associated demyelinating neuropathy: A case report and review of the literature
por: Tamaki, Keiko, et al.
Publicado: (2023)

Natural history and biomarkers in hereditary sensory neuropathy type 1
por: Fridman, Vera, et al.
Publicado: (2015)

Hereditary and Sensory Autonomic Neuropathies
por: Khaledi, Mojdeh, et al.
Publicado: (2012)

Neurological update: hereditary neuropathies
por: Kramarz, Caroline, et al.
Publicado: (2022)

Alopecia Areata and Demyelination as Paraneoplastic Manifestation in Paediatric Hodgkin's Lymphoma
por: Kanaparthi, Shravan, et al.
Publicado: (2018)

Chronic dysimmune neuropathies: Beyond chronic demyelinating polyradiculoneuropathy
por: Khadilkar, Satish V., et al.
Publicado: (2011)

Demyelinating Peripheral Neuropathy Due to Renal Cell Carcinoma
por: Nishioka, Kenya, et al.
Publicado: (2017)

Three cases of acute distal demyelinating neuropathy with recovery
por: Österlund‐Tauriala, Emilia, et al.
Publicado: (2017)

Novel homozygous nonsense mutation in the P5′N‐1 coding gene as an alternative cause for hereditary anemia with basophilic stippling
por: Kirschner, Martin, et al.
Publicado: (2022)

Hereditary sensory neuropathy type I
por: Auer-Grumbach, Michaela
Publicado: (2008)

Medical Management of Hereditary Optic Neuropathies
por: La Morgia, Chiara, et al.
Publicado: (2014)

Neuropathic pain in hereditary peripheral neuropathy
por: Jeong, Na Young, et al.
Publicado: (2013)

Hereditary Neuropathy with Liability to Pressure Palsies
por: Choi, Hyoung Won, et al.
Publicado: (2015)

Chaperonopathies: Spotlight on Hereditary Motor Neuropathies
por: Lupo, Vincenzo, et al.
Publicado: (2016)

Therapeutic Options in Hereditary Optic Neuropathies
por: Amore, Giulia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_18de9aqb5081i1d2uq947547al